Bengaluru, India

Hasibur Rahaman

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 11.8

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Innovations and Contributions of Hasibur Rahaman

Introduction

Hasibur Rahaman is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as T cell activators. With a total of 11 patents to his name, Rahaman's work is instrumental in advancing treatments for viral infections and proliferative disorders, including cancer.

Latest Patents

Among his latest patents are the "Substituted naphthyridinone compounds useful as T cell activators." This patent discloses compounds of a specific formula, along with methods for using these compounds to inhibit the activity of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ). These compounds are particularly useful in treating viral infections and cancer. Another notable patent is for "Substituted pyridopyrimidinonyl compounds useful as T cell activators," which shares similar applications and methodologies.

Career Highlights

Hasibur Rahaman has worked with notable companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Rigel Pharmaceuticals, Incorporated. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Rahaman has collaborated with talented individuals such as Jayakumar Sankara Warrier and Upender Velaparthi. These collaborations have further enriched his research and development efforts.

Conclusion

Hasibur Rahaman's innovative work and numerous patents highlight his significant impact on the pharmaceutical industry. His contributions are paving the way for new treatments that could improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…